FGF12A 通过 CaM 监管和 CaM 独立的机制调节 Nav1.5
bioRxiv : the preprint server for biology
|January 13, 2025
概括
细胞内纤维细胞生长因子12A (FGF12A) 通过两个不同的机制调节心脏通道 (Nav1.5) 功能. FGF12A通过calmodulin (CaM) 调节电压依赖的无活化,并独立于CaM抑制持久晚期电流.
科学领域:
- 心血管生理学心血管生理学
- 分子心脏病学分子心脏病学
- 离子通道生物物理 离子通道生物物理
背景情况:
- 心脏电压通道 (Nav1.5) 对于心脏脱极化和再极化至关重要.
- Nav1.5的失活动力学会影响心律失常,就像重新进入心律失常一样.
- Nav1.5的C终端域 (CTD) 与辅助蛋白相互作用,包括calmodulin (CaM) 和细胞内纤维细胞生长因子12A (FGF12A),调节通道功能.
研究的目的:
- 调查FGF12A和CaM在Nav1.5门关动力学上的调节作用.
- 阐明FGF12A调节Nav1.5通道活动的独特机制.
主要方法:
- 采用切开的瓦斯林间隙 (COVG) 电压电生理学.
- 实验使用了野生类型 (WT) Nav1.5 和一个CaM结合缺陷突变 (IQ/AA) Nav1.5通道.
主要成果:
- FGF12A对WT Nav1.5的激活和非激活电压依赖性产生了最小的影响.
- 在 Nav1.5 CTD (IQ/AA 突变) 上没有 CaM 的情况下,FGF12A 诱导了稳定状态失活的显著转变,独立于 FGF12A 上的 CaM 存在.
- 这些发现表明,FGF12A在Nav1.5.5上有两个不同的调节路径.
结论:
- FGF12A通过CaM调节的机制调节Nav1.5,影响电压依赖的不激活.
- 此外,FGF12A还通过一种独立于CaM的机制抑制持久晚期电流.
- 这些双重机制与了解LQT3突变等条件下Nav1.5功能有关.
相关概念视频
G-Protein Gated Ion Channels
4.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.5K
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
Activation and Inactivation of G Proteins
6.7K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.7K
GPCRs Regulate Adenylyl Cylase Activity
5.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.2K
Immunoglobulin-like Cell Adhesion Molecules
3.2K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.2K
Transducer Mechanism: G Protein–Coupled Receptors
1.8K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.8K


